Cynthia Bedell
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, PI3K/AKT/mTOR signaling in cancer, Chronic Myeloid Leukemia Treatments, Colorectal Cancer Treatments and Studies, CAR-T cell therapy research
Most-Cited Works
- → A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors(2009)266 cited
- → Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors(2013)237 cited
- → Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer(2011)193 cited
- → Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors(2013)149 cited
- → Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma(2015)70 cited
- → Phase I Trial of TGF-β2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine(2011)54 cited
- → Hereditary Inclusion Body Myopathy: Single Patient Response to Intravenous Dosing of GNE Gene Lipoplex(2011)49 cited
- → Summary of bi-shRNA<sup>furin</sup>/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG™) in Advanced Cancer of the Liver(2014)49 cited
- → Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy(2010)27 cited
- → Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer(2015)20 cited